Literature DB >> 1120174

Schizophrenia and organic brain syndrome with trisomy 8 (group-C trisomy 8 [47, XX, 8+]).

M A Sperber.   

Abstract

A supernumerary autosomal syndrome in the C group of submetacentric autosomes has not yet been delineated phenotypically, although cases of an extra C-group autosome have been reported. Recent technical advances (fluorescence and Giemsa banding) now permit positive identification of each autosome. The present case reports the presence of schizophrenia and organic brain syndrome in association with trisomy 8. It is the sixth case of trisomy 8 reported to date. A stress-diathesis model is used to explain the development of the psychiatric disturbances. The patient's autosomal aberration is regarded as diathetic, and the multiple congenital anomalies, surgical interventions, infections, familial, and other environmental responses as stress. This report provides further data for the phenotypic delineation of a trisomy 8 syndrome.

Entities:  

Mesh:

Year:  1975        PMID: 1120174

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

1.  Trisomy 8 syndrome.

Authors:  A R Gagliardi; E H Tajara; M Varella-Garcia; L M Moreira
Journal:  J Med Genet       Date:  1978-02       Impact factor: 6.318

Review 2.  The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Authors:  Emeline Durieux; Françoise Descotes; Claire Mauduit; Myriam Decaussin; Serge Guyetant; Mojgan Devouassoux-Shisheboran
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

3.  Trisomy 8. Report of a mosaic human male with near-normal phenotype and normal IQ, ascertained through infertility.

Authors:  A C Chandley; T B Hargreave; J M Fletcher; M Soos; D Axworthy; W H Price
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

Review 4.  Chromosomal aberrations and schizophrenia. Autosomes.

Authors:  A S Bassett
Journal:  Br J Psychiatry       Date:  1992-09       Impact factor: 9.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.